HEALTH● LOWAug 19 · Aug 19, 2026, 8:39 PM
Moderna, Merck unveil mRNA-based cancer vaccine that cuts spread
Al Jazeera [en]
Moderna's mRNA vaccine Intismeran shows promise, reducing melanoma recurrence and spread in late-stage trials.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH18m agoAbbVie sees positive late-stage results for lutikizumab in hidradenitis suppurativaSeeking Alpha TechHEALTH26m agoThousands of cans of Walmart-brand fruit cocktail recalledThe HillHEALTH47m agoMedicaid billing abuse deprives autistic kids of therapy and taxpayers of trustThe HillHEALTH1h agoEbola: South-East governments step up containment measuresVanguard Nigeria